Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) represent a
significant global burden of morbidity and mortality, with lung injury being the primary cause …

Immune cells are essential for initiating and developing the fibrotic process by releasing
cytokines and growth factors that activate fibroblasts and promote extracellular matrix …

Background Sepsis-related cardiac dysfunction is believed to be a primary cause of high
morbidity and mortality. Metabolic reprogramming is closely linked to NLRP3 inflammasome …

Ethnopharmacological relevance Acute lung injury (ALI) is an aggressive inflammatory
disease of the lungs characterized by a high mortality rate. More and more researchers have …

Background Severe community‐acquired pneumonia (SCAP) is one of the world's most
common diseases and a major etiology of acute respiratory distress syndrome (ARDS) …

Pachymaran (PCP), the major medicinal constituent of Poria cocos, has a regulatory effect
on immunosuppressive lung injury, but its mechanism of action with respect to gut …

M1 (LPS) macrophages are characterized by a high expression of pro-inflammatory
mediators, and distinct metabolic features that comprise increased glycolysis, a broken TCA …

COVID-19 induces acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) and
leads to severe immunological changes that threatens the lives of COVID-19 victims. Studies …

Introduction: Acute aortic dissection (AAD) often leads to the development of acute lung
injury (ALI). However, the early detection and diagnosis of AAD in patients with ALI pose …

Metabolic reprogramming underlies the etiology and pathophysiology of respiratory
diseases such as asthma, idiopathic pulmonary fibrosis (IPF), and chronic obstructive …